| Topic Name: |
M&A question... |
| Message Name: |
... |
| Date Posted: |
04/04/2003 |
| In Reply To: |
well i'm working on an M&A case, the Immunex-Amgen merger from a few years ago.. in regards to the WACC of each respective firm I need both after tax and pre-tax measures.. in regards to cost of debt its pretty straight forward, but what i'm at odds about is whether to use each firms unlevered beta in calculating cost of equity since the tax benefit of debt is included in the levered beta... using an unlevered beta would certainly constitute pre-tax, but would also exclude the incremental risk associated with the debt burden... |
| Message: |
so nobody here knows huh~! awesome!
|
|
